Kirkland represented WeWork, Davis Polk represented an ad hoc group of unsecured noteholders, and Weil represented SoftBank. WeWork Inc. (NYSE: WE) announced a comprehensive restructuring of its...
You must be a Standard 1 Year member to access this content.
Haynes and Boone is advising Heritage Power LLC. Davis Polk is advising GenOn Holdings LLC and certain affiliates and Strategic Value Partners LLC and certain affiliates....
You must be a Standard 1 Year member to access this content.
Weil, Gotshal & Manges LLP represented Portillo’s, while Latham & Watkins LLP represented the underwriters in the offering. Portillo’s Inc. (Nasdaq: PTLO), the fast-casual restaurant concept known...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Portillo’s Inc. (Nasdaq: PTLO), the fast-casual restaurant concept known for its menu of Chicago-style favorites, closed on...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the initial purchasers in the transaction. Kinetik Holdings Inc. (NASDAQ: KNTK) has announced that its subsidiary, Kinetik Holdings LP, has priced its previously...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins advised ProFrac, while Latham & Watkins advised the underwriters in the offering. ProFrac Holding Corp. (ProFrac) has announced the pricing of its initial...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised EP Energy Corporation in the transaction. EP Energy has completed its sale to Verdun Oil Company II, LLC, a portfolio company of EnCap...
You must be a Standard 1 Year member to access this content.
Davis Polk advised GT Gettaxi on the deal, while Latham & Watkins represented Rosecliff Acquisition Corp. Shearman & Sterling advised MCI Capital SA. GT Gettaxi (“Gett”) executed...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Science 37 in the transaction. Science 37, Inc. (Science 37), developer of the Decentralized Clinical Trial Operating SystemTM, and LifeSci Acquisition...
You must be a Standard 1 Year member to access this content.
